Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1981 Nov;44(11):1054–1056. doi: 10.1136/jnnp.44.11.1054

Brain stem and cerebellar dysfunction with Legionnaires' disease.

P C Baker, T R Price, C D Allen
PMCID: PMC491213  PMID: 7334394

Abstract

A 37-year-old man under treatment for manic-depressive illness developed pneumonia identified as Legionnaires' disease accompanied by a severe neurological disorder with profound dysarthria, ataxia, gaze paralysis, and downbeat nystagmus. At review six months later, he has made only a partial recovery with persisting limb and gait ataxia. Difficulties in diagnosing neurological complications of Legionnaires' disease in a patient with a psychiatric disorder requiring psychotropic medication are discussed.

Full text

PDF
1054

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baastrup P. C., Hollnagel P., Sorensen R., Schou M. Adverse reactions in treatment with lithium carbonate and haloperidol. JAMA. 1976 Dec 6;236(23):2645–2646. [PubMed] [Google Scholar]
  2. Cohen W. J., Cohen N. H. Lithium carbonate, haloperidol, and irreversible brain damage. JAMA. 1974 Dec 2;230(9):1283–1287. [PubMed] [Google Scholar]
  3. Friedman H. M. Legionnaires' disease in non-Legionnaires. A report of five cases. Ann Intern Med. 1978 Mar;88(3):294–302. doi: 10.7326/0003-4819-88-3-294. [DOI] [PubMed] [Google Scholar]
  4. Gregory D. W., Schaffner W., Alford R. H., Kaiser A. B., McGee Z. A. Sporadic cases of Legionnaires' disease: the expanding clinical spectrum. Ann Intern Med. 1979 Apr;90(4):518–521. doi: 10.7326/0003-4819-90-4-518. [DOI] [PubMed] [Google Scholar]
  5. Keys T. F. Legionnaires' disease: a review of the epidemiology and clinical manifestations of a newly recognized infection. Mayo Clin Proc. 1980 Mar;55(3):129–137. [PubMed] [Google Scholar]
  6. Lattimer G. L., Rhodes L. V., 3rd Legionnaires' disease. Clinical findings and one-year follow-up. JAMA. 1978 Sep 8;240(11):1169–1171. doi: 10.1001/jama.240.11.1169. [DOI] [PubMed] [Google Scholar]
  7. Lees A. W., Tyrrell W. F. Severe cerebral disturbance in legionnaires' disease. Lancet. 1978 Dec 23;2(8104-5):1336–1337. doi: 10.1016/s0140-6736(78)91974-8. [DOI] [PubMed] [Google Scholar]
  8. Shetty K. R., Cilyo C. L., Starr B. D., Harter D. H. Legionnaires' disease with profound cerebellar involvement. Arch Neurol. 1980 Jun;37(6):379–380. doi: 10.1001/archneur.1980.00500550081014. [DOI] [PubMed] [Google Scholar]
  9. Terranova W., Cohen M. L., Fraser D. W. 1974 outbreak of Legionnaires' Disease diagnosed in 1977. Clinical and epidemiological features. Lancet. 1978 Jul 15;2(8081):122–124. doi: 10.1016/s0140-6736(78)91507-6. [DOI] [PubMed] [Google Scholar]
  10. Wong K. H., Moss C. W., Hochstein D. H., Arko R. J., Schalla W. O. "Endotoxicity" of the Legionnaires' disease bacterium. Ann Intern Med. 1979 Apr;90(4):624–627. doi: 10.7326/0003-4819-90-4-624. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES